FDA Inspection 1196992 — Carter BloodCare - Irving
The FDA completed an inspection of Carter BloodCare - Irving on Feb 9, 2023 in Irving, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 9, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Irving, TX (United States)